In a recent announcement, DUALITYBIO-B (09606) disclosed that it has submitted the necessary application materials to the Shanghai Stock Exchange for its proposed issuance of Renminbi-denominated shares.
The application package includes the draft prospectus for the initial public offering of ordinary A-shares and their intended listing on the Science and Technology Innovation Board, commonly known as the STAR Market.
The company has confirmed receipt of an official acceptance notice from the Shanghai Stock Exchange in response to its application for the Renminbi share issuance.
The full A-share prospectus will be made available for public viewing on the official website of the Shanghai Stock Exchange.
Comments